Sands Capital Global Growth Fund, in its Q2 2026 investor letter, expressed optimism about the long-term AI potential of Intuitive Surgical (NASDAQ:ISRG), a leader in robotic-assisted surgery. The fund believes that despite recent pressure on ISRG's stock price, its fundamentals remain strong, with Q1 2026 results exceeding expectations. The fund anticipates ISRG will launch multiple AI features in the coming years, which are expected to accelerate the adoption of robotic surgery and create high-margin software licensing opportunities.